April 13, 2022
By Susan Murphy
Researchers at Mayo Clinic’s Center for Individualized Medicine have devised an immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors.
March 31, 2022
By Susan Murphy
Alejandro Mirazo, 56, never imagined his genetic test results would reveal a hereditary link to cancer, or that his findings would potentially save his life. He had participated in a preemptive DNA research sequencing study for Mayo Clinic’s Center for Individualized Medicine in fall 2021 solely to contribute to medical research. As a Mexican American, he also wanted to add diversity to Mayo Clinic’s genomic dataset.
March 22, 2022
The results from the “Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment” (RIGHT 10K) study strongly suggest that preemptive testing could benefit nearly every patient at some point, particularly when the testing extends beyond DNA variants already known to influence drug metabolism.
March 16, 2022
Mayo Clinic researchers have taken the first step in using artificial intelligence (AI) to predict early outcomes with antidepressants in children and adolescents with major depressive disorder, in a study published in The Journal of Child Psychology and Psychiatry.
March 11, 2022
By Susan Murphy
A growing number of people are dying from antibiotic-resistant infections. These infections are fueled by microbial species that are mutating to evade the drugs developed to destroy them. More than 1.2 million people worldwide died in 2019 from antibiotic-resistant infections. In response, a team of researchers from Mayo Clinic’s Center for Individualized Medicine has developed […]
January 13, 2022
The Minnesota Partnership for Biotechnology and Medical Genomics have announced their 2022 research awardees. This marks the partnership’s 18th year of spearheading new scientific ideas from Minnesota to improve the health of, and health care for, Minnesotans.
September 20, 2021
Mayo Clinic research is dedicated to finding solutions for patients who were infected with COVID-19 and the many affected by the long-term symptoms of COVID-19 ― what the National Institutes of Health (NIH) refers to as “long COVID” or post-acute sequelae. In response to great unmet patient need, the NIH launched a new research initiative […]
Tags: center for individualized medicine, covid-19, Dr. Mine Cicek, Dr. R.Ross Reichard, Dr. Ryan Hurt, Dr. Stephen Thibodeau, Dr. Thomas Flotte, individualized medicine, long-COVID, mayo clinic, mayo clinic laboratories, medical research
August 9, 2021
April 3, 2018
By Sharon Rosen
Gene editing, artificial intelligence, pharmacogenomics and a new era of genomic testing to identify and hopefully treat inherited cancer are just a few of the emerging areas of precision medicine that have the potential to transform patient care. These are among the hot topics in precision medicine experts from Mayo Clinic and around the world […]
Tags: #Artificial Intelligence, #CIMCon18, #Dr. Eric Green, #Dr. Heidi Rehm, #genomic testing, #Individualizing Medicine Conference: Advancing Care Through Genomics, #personalized diet, #prenatal testing, #rare and undiagnosed diseases, center for individualized medicine, Dr. Timothy Curry, gene editing
November 2, 2017
Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer. This discovery can guide health care providers to individualized treatments for castration-resistant prostate cancer, a deadly disease that does not respond to standard hormone therapy. Several U.S. Food and Drug […]
Tags: Advanced prostate cancer, castration-resistant prostate cancer, center for individualized medicine, Dr. Keith Stewart, Dr. Liewei Wang, Dr. Manish Kohli, individualized medicine, medical research, personalized medicine, Precision Medicine, Prostate Cancer, RNA sequencing